Skip to main content
. 2021 Aug 27;8:712070. doi: 10.3389/fmed.2021.712070

Figure 1.

Figure 1

Probability of overall survival (OS) by Kaplan-Meier estimates in patients with MM treated with VMP (total patients 164). The median OS was 34.33 mo. VMP, bortezomib plus melphalan-prednisone.